|
Volumn 168, Issue 2, 2013, Pages 163-167
|
Sorafenib therapy decreases the clearance of thyrotropin.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBANILAMIDE DERIVATIVE;
DRUG DERIVATIVE;
NICOTINAMIDE;
PROTEIN KINASE INHIBITOR;
SORAFENIB;
THYROTROPIN;
AGED;
ARTICLE;
CARCINOMA;
DOSE RESPONSE;
FEMALE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
THYROID FUNCTION TEST;
THYROID TUMOR;
AGED;
AGED, 80 AND OVER;
CARCINOMA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NIACINAMIDE;
PHENYLUREA COMPOUNDS;
PROTEIN KINASE INHIBITORS;
THYROID FUNCTION TESTS;
THYROID NEOPLASMS;
THYROTROPIN;
|
EID: 84874524453
PISSN: None
EISSN: 1479683X
Source Type: None
DOI: 10.1530/EJE-12-0828 Document Type: Article |
Times cited : (16)
|
References (0)
|